RAPAMYCIN
MODERATE
▲ +7 papers · 7d
METFORMIN
MODERATE
▲ +9 papers · 7d
NMN
EMERGING
▲ +10 papers · 7d
NR
EMERGING
▲ +9 papers · 7d
D + Q
EMERGING
▲ +13 papers · 7d
GLP-1 AGONISTS
STRONG
▲ +10 papers · 7d
SGLT2 INHIBITORS
STRONG
▲ +12 papers · 7d
ACARBOSE
MODERATE
▲ +12 papers · 7d
TAURINE
EMERGING
▲ +13 papers · 7d
BERBERINE
EMERGING
▲ +11 papers · 7d
17Α-ESTRADIOL
EMERGING
▲ +4 papers · 7d
SPERMIDINE
EMERGING
▲ +15 papers · 7d
UROLITHIN A
EMERGING
▲ +11 papers · 7d
FISETIN
EMERGING
▲ +9 papers · 7d
RAPAMYCIN
MODERATE
▲ +7 papers · 7d
METFORMIN
MODERATE
▲ +9 papers · 7d
NMN
EMERGING
▲ +10 papers · 7d
NR
EMERGING
▲ +9 papers · 7d
D + Q
EMERGING
▲ +13 papers · 7d
GLP-1 AGONISTS
STRONG
▲ +10 papers · 7d
SGLT2 INHIBITORS
STRONG
▲ +12 papers · 7d
ACARBOSE
MODERATE
▲ +12 papers · 7d
TAURINE
EMERGING
▲ +13 papers · 7d
BERBERINE
EMERGING
▲ +11 papers · 7d
17Α-ESTRADIOL
EMERGING
▲ +4 papers · 7d
SPERMIDINE
EMERGING
▲ +15 papers · 7d
UROLITHIN A
EMERGING
▲ +11 papers · 7d
FISETIN
EMERGING
▲ +9 papers · 7d
Vol.
IV
· No.
19
Tuesday, June 23, 2026
Issue:
Spring · 2026
Established · MMXXVI
Geroevidence
— The evidence base for longevity medicine —
Indexed by
PubMed
·
CTG
·
Cochrane
Editorial team ·
geroevidence.com
Subscription ·
app.geroevidence.com
Home
Interventions
Evidence
Blog
About
Roadmap
Pricing
Sign in
Start free trial →
Geroevidence
·
Editorial desk
·
Clinical Trials
Clinical Trials
Trial readouts, protocol analyses, and enrollment updates.
3 articles in this category
·
← All categories
§ Clinical Trials · 3 articles
Could semaglutide become an anti-aging drug? The SELECT trial and beyond
Semaglutide's weight-loss story is well known. The cardiovascular outcome data is the more significant — and less discussed — longevity story.
June 24, 2026 · 11 min read
Rapamycin dosing in published clinical trials: what the research has actually tested
A summary of dosing regimens used in published rapamycin longevity trials. This describes what researchers have studied — it is not a dosing recommendation.
June 24, 2026 · 10 min read
The TAME trial explained: what metformin's biggest longevity test will actually tell us
TAME is the most significant longevity trial running. What the trial design means, what a positive result would and would not prove, and what interim signals look like.
May 10, 2026 · 11 min read